Group 1 - The core viewpoint of the news is that Zhenhua Convertible Bonds have shown a price increase and a notable premium rate, indicating investor interest and market activity [1] - Zhenhua Convertible Bonds have a credit rating of "AA" and a maturity period of 6 years, with a structured interest rate that increases over time [1] - The conversion price for the bonds is set at 8.2 yuan, with the conversion period starting on January 20, 2025 [1] Group 2 - Hubei Zhenhua Chemical Co., Ltd. is recognized as the largest listed chromium salt company globally, with significant production capacity in Vitamin K3 [2] - The company operates high-tech production bases in Hubei and Chongqing, and it has established well-known brands in the industry [2] - For the first half of 2025, Zhenhua achieved a revenue of 2.1896 billion yuan, reflecting a year-on-year increase of 10.17%, and a net profit of 297.9 million yuan, up 23.62% year-on-year [2] - The concentration of shareholding is relatively high, with the top ten shareholders holding a combined 48.79% of shares [2]

Group 1 - The core viewpoint of the news is that Zhenhua Convertible Bonds experienced a decline in trading, with a current price of 280.977 yuan per bond and a trading volume of 70.0547 million yuan, indicating a conversion premium rate of 21.94% [1] - Zhenhua Convertible Bonds have a credit rating of "AA" and a maturity period of 6 years, with a coupon rate that increases over the years, starting from 0.20% in the first year to 2.00% in the sixth year [1] - The conversion price for the bonds is set at 8.2 yuan, with the conversion period starting on January 20, 2025 [1] Group 2 - Hubei Zhenhua Chemical Co., Ltd. is recognized as the largest listed chromium salt company globally, with significant production capacity in Vitamin K3 [2] - The company operates high-tech enterprises with production bases in Huangshi, Hubei, and Tongnan, Chongqing, and has established well-known brands "Minzhong" and "Chugao" [2] - For the first half of 2025, Zhenhua achieved a revenue of 2.1896 billion yuan, a year-on-year increase of 10.17%, and a net profit attributable to shareholders of 297.9 million yuan, reflecting a year-on-year increase of 23.62% [2] - The concentration of shareholding is relatively high, with the top ten shareholders holding a combined 48.79% of shares, and the average holding amount per shareholder is 597,300 yuan [2]

| 证券代码：603067 | 证券简称：振华股份 | | --- | --- | | 债券代码：113687 | 债券简称：振华转债 | | | 公告编号：2025-040 | 湖北振华化学股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 湖北振华化学股份有限公司（以下简称"公司"）根据上海证券交易所《上 市公司自律监管指引第 3 号——行业信息披露第十三号——化工》 （2022 年修 订）和《关于做好主板上市公司 2025 年半年度报告披露工作的重要提醒》的要 求，现将 2025 年半年度主要经营数据披露如下： 二、主要产品和原材料的价格变动情况 （一）主要产品的价格变动情况（不含税） 三、报告期内无其他对公司生产经营具有重大影响的事项。 四、其他说明 以上经营数据未经审计，为投资者及时了解公司生产经营情况之用，并未对 公司未来经营情况作出任何明示或默示的预测或保证，敬请投资者审慎使用。 特此公告。 湖北振华化学股份有限公司 | | 年半年 2024 | 年半年度 20 ...

Group 1 - The core viewpoint of the news is that Zhenhua Convertible Bonds have shown a price increase and a notable premium rate, indicating investor interest and market activity [1] - Zhenhua Convertible Bonds have a credit rating of "AA" and a maturity period of 6 years, with a structured coupon rate increasing over the years [1] - The conversion price for the bonds is set at 8.2 yuan, with the conversion period starting on January 20, 2025 [1] Group 2 - Hubei Zhenhua Chemical Co., Ltd. is recognized as the largest listed chromium salt company globally, with significant production capacity in Vitamin K3 [2] - The company operates high-tech production bases in Hubei and Chongqing, and it has established well-known brands in the industry [2] - For the first quarter of 2025, Zhenhua achieved a revenue of 1.0198 billion yuan, a year-on-year increase of 7.59%, and a net profit of 117.4 million yuan, reflecting a 37.27% increase [2] - The concentration of shareholding is relatively high, with the top ten shareholders holding 47.57% of the shares [2]

截至2025年3月，振华股份筹码集中度较集中。十大股东持股合计占比47.57%，十大流通股东持股合计 占比47.57%。股东人数1.859万户，人均流通股2.739万股，人均持股金额34.07万元。 7月21日，振华转债盘中上涨2.33%报206.527元/张，成交额3396.55万元，转股溢价率17.08%。 资料显示，振华转债信用级别为"AA"，债券期限6年（本次发行的可转债票面利率为第一年0.20%、第 二年0.40%、第三年0.80%、第四年1.50%、第五年1.80%、第六年2.00%），对应正股名称为振华股份， 转股开始日为2025年1月20日，转股价8.2元。 可转换债券简称可转债，是一种可以在特定时间、按特定条件转换为普通股票的特殊企业债券，兼具债 权和股权的特征。一般而言，持有人可按照发行时约定的价格将债券转换成公司的普通股票的债券。如 果债券持有人不想转换，则可以继续持有债券，直到偿还期满时收取本金和利息，或者在流通市场出售 变现。 资料显示，湖北振华化学股份有限公司(股票代码SH.603067)是目前全球范围内最具规模的铬盐上市企 业,公司维生素K3的生产能力位居全球前列。公司是高新技术 ...

Company Overview - Hubei Zhenhua Chemical Co., Ltd. (stock code SH.603067) is currently the largest listed chromium salt company globally and ranks among the top producers of Vitamin K3 [2] - The company is recognized as a high-tech enterprise with production bases in Huangshi, Hubei, and Tongnan, Chongqing, and owns two well-known brands, "Minzhong" and "Chugao" [2] - Major products include sodium dichromate, potassium dichromate, chromium trioxide, chromium oxide green, basic chromium sulfate, refined sodium dichromate, chrome yellow, metallic chromium, ultra-fine aluminum hydroxide, and Vitamin K3 [2] Financial Performance - For the period from January to March 2025, the company achieved an operating income of 1.0198 billion yuan, representing a year-on-year increase of 7.59% [2] - The net profit attributable to shareholders was 117.4 million yuan, reflecting a year-on-year increase of 37.27% [2] - The net profit after deducting non-recurring gains and losses was 114.9 million yuan, which is a year-on-year increase of 29.93% [2] Shareholder Structure - As of March 2025, the concentration of shares is relatively high, with the top ten shareholders holding a combined 47.57% of the shares [2] - The total number of shareholders is approximately 18,590, with an average of 27,390 circulating shares per shareholder and an average holding amount of 340,700 yuan [2] Market Activity - On July 14, XD Zhenhua's convertible bonds rose by 2.0% to 201.008 yuan per share, with a trading volume of 95.5918 million yuan and a conversion premium rate of 11.75% [1] - The convertible bonds have a credit rating of "AA" and a term of 6 years, with a coupon rate that increases over the years, starting from 0.20% in the first year to 2.00% in the sixth year [1] - The conversion price for the bonds is set at 8.2 yuan, with the conversion period starting on January 20, 2025 [1]

Company Overview - Hubei Zhenhua Chemical Co., Ltd. is currently the largest listed chromium salt company globally, with significant production capacity for Vitamin K3 [2] - The company operates high-tech enterprises with production bases in Huangshi, Hubei, and Tongnan, Chongqing, and owns well-known brands "Minzhong" and "Chugao" [2] - Zhenhua's main products include sodium dichromate, potassium dichromate, chromium trioxide, chromium oxide green, basic chromium sulfate, refined yellow powder, chromium yellow, metallic chromium, ultra-fine aluminum hydroxide, and Vitamin K3 [2] Financial Performance - For the period of January to March 2025, Zhenhua achieved a revenue of 1.0198 billion yuan, representing a year-on-year increase of 7.59% [2] - The net profit attributable to shareholders was 117.4 million yuan, reflecting a year-on-year increase of 37.27% [2] - The net profit after deducting non-recurring items was 114.9 million yuan, showing a year-on-year increase of 29.93% [2] Shareholder Structure - As of March 2025, the concentration of shares is relatively high, with the top ten shareholders holding a combined 47.57% of the shares [2] - The total number of shareholders is 18,590, with an average of 27,390 circulating shares per person and an average holding amount of 340,700 yuan [2] Convertible Bond Information - Zhenhua's convertible bond experienced a decline of 3.55%, trading at 198.886 yuan per bond, with a transaction volume of 104 million yuan and a conversion premium rate of 8.95% [1] - The convertible bond has a credit rating of "AA" and a maturity of 6 years, with a coupon rate that increases over the years, starting from 0.20% in the first year to 2.00% in the sixth year [1] - The conversion price for the bond is set at 8.2 yuan, with the conversion period starting on January 20, 2025 [1]

Group 1 - The company, Hubei Zhenhua Chemical Co., Ltd., has issued convertible bonds totaling RMB 406.21 million, with a maturity of 6 years and a face value of RMB 100 per bond [3][4][19] - The bonds were approved by the Shanghai Stock Exchange and the China Securities Regulatory Commission, with the first issuance date on August 2, 2024 [3][4] - The company reported a revenue of RMB 406,671.94 million for 2024, representing a year-on-year increase of 9.95%, and a net profit of RMB 47,287.64 million, up 27.53% from the previous year [19][20] Group 2 - The bonds have a tiered interest rate structure, starting at 0.20% in the first year and increasing to 2.00% in the sixth year [4][5] - The initial conversion price for the bonds is set at RMB 11.64 per share, with provisions for adjustments based on corporate actions such as stock dividends and capital increases [6][8] - The company has established a dedicated fund management system for the raised capital, ensuring compliance with regulatory requirements and protecting investor interests [20][21] Group 3 - The company’s total assets increased by 18.98% year-on-year, reaching RMB 505,580.73 million by the end of 2024 [20] - The company’s net assets attributable to shareholders rose by 12.59% to RMB 315,899.40 million [20] - The company is engaged in the production and sale of chromium chemicals and related products, including sodium dichromate and potassium dichromate [19]

Group 1 - Mianyang is focusing on attracting young talent to enhance its urban public services and create youth-friendly parks, with a significant increase in the number of skilled professionals moving to the city [6][7][8] - Over the past three years, Mianyang has attracted 86,000 talents, including over 15,000 master's and doctoral graduates, contributing to a projected increase of 11,000 permanent residents in 2024 [7][8] - The city aims to leverage its strengths in technology and industry to facilitate the transformation of new technologies into new industries, addressing the historical disconnect between research and industrial application [7][8] Group 2 - Mianyang has established a robust platform for innovation, with 28 signed projects in the nuclear medical health industry, totaling over 22.3 billion yuan in investment [7] - The magnetic materials industry in Mianyang is also developing, with companies like Juxing Permanent Magnet producing high-temperature resistant magnetic steel, expected to achieve a revenue of 2 billion yuan this year [7] - The Mianyang Technology City has launched a pilot service platform for rapid prototyping, which has attracted significant investment and interest from venture capital funds, indicating a growing ecosystem for startups [7][8] Group 3 - The city is implementing policies such as "bringing soil transplant" to encourage teams to carry their research achievements into entrepreneurship, retaining their original staffing for four years [7] - Mianyang's urban development has integrated youthful elements, transforming areas into vibrant cultural and recreational spaces, which has enhanced the city's appeal to young professionals [8] - The region's GDP growth has consistently ranked among the top three in the province over the past three years, reflecting the positive impact of innovation and talent influx [8]